The Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) hosts a roundtable on cell and gene therapy from 9 a.m. to 12 p.m. on June 5.
Roundtable Participants:
Jeff Allen, PhD, President and CEO
Friends of Cancer Research
Ron Bartek, Co-founder and President
Friedreich’s Ataxia Research Alliance
Allyson Berent, DVM, DACVIM, Chief Scientific Officer
Foundation for Angelman Syndrome Therapeutics
Co-Director
Angelman Syndrome Biomarker and Outcome Measure Consortium
Catherine Bollard, MBChB, MD
Senior Vice President and Chief Research Officer
Director, Center for Cancer and Immunology Research
Professor of Pediatrics and Immunology
Children’s National and The George Washington University…